S2 Genomics - About the company
S2 Genomics is an acquired company based in Livermore (United States), founded in 2016 by Stevan Jovanovich. It operates as a Developer of automated sample preparation systems for genomics. S2 Genomics has raised $16M in funding from Broadoak Capital Partners and RCT. The company has 129 active competitors, including 40 funded and 30 that have exited. Its top competitors include companies like Nanopore Technologies, PacBio and Complete Genomics.
Company Details
Developer of automated sample preparation systems for genomics. The company is developing single-cell sample preparations solutions for NGS. Their systems are used for processing tissues and liquid samples into genomic samples. The company is also developing a spatial sequencing technology that will capture the spatial location like 3-dimensional coordinates, of single cells in tissue for NGS readout.
- Website
- s2genomics.com
- Email ID
- *****@s2genomics.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2016
Location
Livermore, United States
Stage
Acquired
Total Funding
$16M in 3 rounds
Latest Funding Round
Investors
Ranked
5th among 129 active competitors
Employee Count
5 as on Aug 31, 2026
Similar Companies
Exit Details
Acquired
S2 Genomics's acquisition details
S2 Genomics got acquired on Sep 17, 2025.
Click here to take a look at S2 Genomics's acquisition in detail
Sign up to download S2 Genomics' company profile
S2 Genomics's funding and investors
S2 Genomics has raised a total funding of $16M over 3 rounds. Its first funding round was on Jun 13, 2018. Its latest funding round was a Series A round on Jan 23, 2024 for $*****. 2 investors participated in its latest round. S2 Genomics has 8 institutional investors.
Here is the list of recent funding rounds of S2 Genomics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 23, 2024 | 1257194 | Series A | 9872380 | 5365324 | 3997677 | 3687410 |
May 20, 2021 | 4925324 | Conventional Debt | 4174896 | 6566235 | 8988817 | 9717644 |
Jun 13, 2018 | 1245098 | Grant (prize money) | 1674369 | 5382087 | 2076551 |
View details of S2 Genomics's funding rounds and investors
S2 Genomics' founders and board of directors
Founder? Claim ProfileThe founders of S2 Genomics is Stevan Jovanovich. Stevan Jovanovich is the CEO of S2 Genomics.
Here are the details of S2 Genomics' key team members:
- Stevan Jovanovich: Founder & CEO of S2 Genomics. Contact Info: 1 email address
View details of S2 Genomics's Founder profiles and Board Members
S2 Genomics' employee count trend
S2 Genomics has 5 employees as of Aug 26. Here is S2 Genomics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
S2 Genomics's Competitors and alternates
Top competitors of S2 Genomics include Nanopore Technologies, PacBio and Complete Genomics. Here is the list of Top 10 competitors of S2 Genomics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Nanopore Technologies 2005, Oxford (United Kingdom), Public | Manufacturer of portable and benchtop devices for real-time DNA sequencing | $1.34B | 75/100 | |
2nd | PacBio 2004, Menlo Park (United States), Public | Developer of instrument systems and software for real-time sequencing of single-molecules | $410M | 72/100 | |
3rd | Complete Genomics 2006, San Jose (United States), Acquired | Developer of DNA sequencing platform for human genome sequencing and analysis | $125M | 66/100 | |
4th | Ultima Genomics 2016, Newark (United States), Series D | Developer of high-throughput NGS instrument for research | $600M | 62/100 | |
5th | S2 Genomics 2016, Livermore (United States), Acquired | Developer of automated sample preparation systems for genomics | $16M | 59/100 | |
6th | Bionano 2002, San Diego (United States), Public | Provider of genome analysis solutions to researchers and clinicians | $124M | 58/100 | |
7th | Singular Genomics 2016, San Diego (United States), Acquired | Provider of next-generation gene sequencing and multi-omics technologies | - | 57/100 | |
8th | Bioskryb 2018, Durham (United States), Seed | Developer of a genome sequencing and amplification system | $11.5M | 55/100 | |
9th | Protillion 2018, Burlingame (United States), Series A | Provider of platform for protein analysis | $19M | 53/100 | |
10th | Omniome 2013, San Diego (United States), Acquired | Provider of genome sequencing platform | $160M | 51/100 |
Looking for more details on S2 Genomics's competitors? Click here to see the top ones
S2 Genomics's Investments and acquisitions
S2 Genomics has made no investments or acquisitions yet.
Reports related to S2 Genomics
Here is the latest report on S2 Genomics's sector:
News related to S2 Genomics
•
Precision Cell Systems Acquires S2 Genomics and ORFLO to Consolidate Cell Analysis TechnologiesPR Newswire•Sep 17, 2025•Orflo, S2 Genomics, Precision Cell Systems
•
S2 Genomics Raises Series A Round Led by BroadOak Capital Partners and RCTintelligence360•Jan 24, 2024•S2 Genomics, Broadoak Capital Partners, RCT, RCT Ventures
•
S2 Genomics Announces Distribution Agreement with Bonsailab to Serve Iberian PeninsulaBusiness Wire•Jan 11, 2023•Bonsai Lab, S2 Genomics
•
S2 Genomics Strikes Distribution Deal for Sample Prep System With Proteigene in FranceGenomeWeb•Sep 21, 2022•S2 Genomics, Proteigene
•
S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve ScandinaviaBusiness Wire•Sep 06, 2022•S2 Genomics, Techtum
•
•
S2 Genomics signs Eisenberg for Israel Distribution for the Singulator™ 100 System to Accelerate Single-Cell Genomics ResearchBusiness Wire•Aug 30, 2022•S2 Genomics
•
S2 Genomics Announces the NIC+ Cartridge for Isolating Nuclei from Sub-20 mg Tissue SamplesBusiness Wire•Jun 06, 2022•S2 Genomics
•
Mission Bio Partners with S2 Genomics to Offer Robust Solid Tumor Sample Prep for Single-Cell DNA AnalysisPR Newswire•Apr 19, 2022•S2 Genomics, Mission Bio
•
Applied Cells, S2 Genomics Ink Marketing Pact for Sample Prep TechnologiesGenomeWeb•Feb 09, 2022•Applied Cells, S2 Genomics
Are you a Founder ?
FAQs about S2 Genomics
Explore our recently published companies
- Al Hasanain - Bangladesh based, 2018 founded, Unfunded company
- Agile Navigators - Czech Republic based, 2018 founded, Unfunded company
- Allardyce Academy - 2024 founded, Unfunded company
- Zitzelsberger Gebaudereinigung - Emmendingen based, 2003 founded, Unfunded company
- AGConsult - Antarctica based, 2001 founded, Unfunded company
- VADAROD - Belarus based, 2012 founded, Unfunded company